Your browser doesn't support javascript.
loading
Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study.
Wang, Li; Jia, Kegang; Li, Fang; Zhang, Chenxu; Feng, Gang; Du, Jun.
Afiliación
  • Wang L; Oncology Department of Jiangsu Institute of Cancer Research (Jiangsu Cancer Hospital), Nanjing, China.
  • Jia K; Department of Thoracic Surgery, Sichuan Provincial People's Hospital, Chengdu, China.
  • Li F; Chengdu Diao Pharmaceutical Group Co, Ltd, Chengdu, China.
  • Zhang C; Chengdu Diao Pharmaceutical Group Co, Ltd, Chengdu, China.
  • Feng G; Department of Thoracic Surgery, Sichuan Provincial People's Hospital, Chengdu, China.
  • Du J; Chengdu Diao Pharmaceutical Group Co, Ltd, Chengdu, China.
Front Pharmacol ; 12: 719802, 2021.
Article en En | MEDLINE | ID: mdl-34539404
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China